- On-Demand
New Horizons in Multiple Myeloma Treatment: The Promise of CAR-T for Early Relapsed Disease
- Credit: 1.00hr(s)
- AAPA, CME, CPE, IPCE, NCPD
- May 31, 2023 —
- May 30, 2024
- Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
- Specialties: CAR T-Cell Therapy, Multiple Myeloma
- Location: Internet Activity Enduring
Despite remarkable progress, significant gaps remain in meeting the needs of patients facing relapse in multiple myeloma, particularly among patients with early relapse or triple-class exposed disease. Join us for a groundbreaking Special Edition Med Table Talk episode where we delve into the latest advancements in the treatment of relapsed multiple myeloma (RRMM). This candid conversation between esteemed faculty experts discusses the latest clinical evidence and rationale for CAR T-cell therapy in early versus late relapse settings and embraces a future pathway where highly effective treatments may be delivered earlier to support increasingly durable responses for complex patient populations.